"Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: https://www.sciencedirect.com/science/article/pii/S2667368124000238
1) GLP-1 Drugs Cause Big Drops in Food Intake
The review looked at multiple clinical studies of people with obesity (with or without type 2 diabetes) who were taking GLP-1 or GLP-1/GIP agonist medications. Across these studies:
👉 Patients cut their total calorie intake by 16–39 % while on therapy.
That’s a massive drop — but it wasn’t just about eating less food.
2) The Composition of What They Eat Matters — But We Don’t Know Enough Yet
Even though overall calories dropped significantly, few studies measured what people were actually putting on their plate — e.g., how much protein, carbs, vitamins or minerals they consumed while on these drugs.
That’s a big deal, because what someone eats — not just how much — determines whether their body maintains energy, strength and metabolism.
3) Appetite Suppression Is Powerful — But It’s Not the Whole Story
GLP-1 medications work by:
âś” Slowing gastric emptying (food stays in the stomach longer)
âś” Reducing hunger signals to the brain
This leads to patients eating much less naturally, without force-feeding or willpower — but it also means reduced intake of crucial nutrients like protein and complex carbohydrates, which are essential to sustain:
âś… Muscle mass
âś… Energy levels
âś… Bone health
âś… Metabolic resilience
Without enough of those nutrients, the body can enter a “low fuel” mode where resistance training, daily activity and metabolic functions become much harder.
4) Knee-Jerk Appetite Suppression Isn’t Enough for Long-Term Health
The research highlights a practical gap:
👉 We understand that GLP-1 drugs reduce appetite and calories
👉 But we don’t yet have good guidelines around how patients should eat while on them
That matters because calorie reduction without nutrient adequacy can lead to:
➡ Loss of lean muscle
➡ Low energy
➡ Poor exercise tolerance
➡ Metabolic slowdown
➡ Greater challenge maintaining weight off medication
…even though the drugs are doing their job on appetite.
5) Why This Matters for Real People
From a lay perspective, here’s the critical takeaway:
If someone eats dramatically less because the drug suppresses hunger, but doesn’t prioritise nutrient-rich foods — especially enough protein and balanced carbohydrates — they can lose too much muscle and have less energy to be active or do resistance training.
And that’s exactly the scenario this review flagged as poorly studied and not well addressed yet in clinical practice.
🔍 What This Tells Us About GLP-1 Therapy
GLP-1 medications are superb at helping people eat less.
But science right now is very clear about this gap:
âś” We know how much people eat less
✔ We don’t yet know enough about the nutritional quality of what they eat
✔ And that “unknown” is critically important for sustained metabolic health and strength
In plain language:
Cutting calories alone isn’t the same thing as eating well.
Suppressing appetite won’t automatically provide the protein, nutrients or energy your body needs to preserve muscle, exercise effectively, stay mentally sharp, or maintain long-term metabolic health.
Why This Should Matter to Clinicians and Patients
This narrative review isn’t saying “don’t use GLP-1 drugs” — it’s saying:
👉 We must pair pharmacological appetite suppression with purposeful nutritional support
👉 We must prioritise whole foods, adequate protein and balanced macronutrients
👉 We must support patients with structured eating plans, not just reduced calories
That’s the missing piece if the goal isn’t merely temporary weight loss, but lasting metabolic health and strength.
1) GLP-1 Drugs Cause Big Drops in Food Intake
The review looked at multiple clinical studies of people with obesity (with or without type 2 diabetes) who were taking GLP-1 or GLP-1/GIP agonist medications. Across these studies:
👉 Patients cut their total calorie intake by 16–39 % while on therapy.
That’s a massive drop — but it wasn’t just about eating less food.
2) The Composition of What They Eat Matters — But We Don’t Know Enough Yet
Even though overall calories dropped significantly, few studies measured what people were actually putting on their plate — e.g., how much protein, carbs, vitamins or minerals they consumed while on these drugs.
That’s a big deal, because what someone eats — not just how much — determines whether their body maintains energy, strength and metabolism.
3) Appetite Suppression Is Powerful — But It’s Not the Whole Story
GLP-1 medications work by:
âś” Slowing gastric emptying (food stays in the stomach longer)
âś” Reducing hunger signals to the brain
This leads to patients eating much less naturally, without force-feeding or willpower — but it also means reduced intake of crucial nutrients like protein and complex carbohydrates, which are essential to sustain:
âś… Muscle mass
âś… Energy levels
âś… Bone health
âś… Metabolic resilience
Without enough of those nutrients, the body can enter a “low fuel” mode where resistance training, daily activity and metabolic functions become much harder.
4) Knee-Jerk Appetite Suppression Isn’t Enough for Long-Term Health
The research highlights a practical gap:
👉 We understand that GLP-1 drugs reduce appetite and calories
👉 But we don’t yet have good guidelines around how patients should eat while on them
That matters because calorie reduction without nutrient adequacy can lead to:
➡ Loss of lean muscle
➡ Low energy
➡ Poor exercise tolerance
➡ Metabolic slowdown
➡ Greater challenge maintaining weight off medication
…even though the drugs are doing their job on appetite.
5) Why This Matters for Real People
From a lay perspective, here’s the critical takeaway:
If someone eats dramatically less because the drug suppresses hunger, but doesn’t prioritise nutrient-rich foods — especially enough protein and balanced carbohydrates — they can lose too much muscle and have less energy to be active or do resistance training.
And that’s exactly the scenario this review flagged as poorly studied and not well addressed yet in clinical practice.
🔍 What This Tells Us About GLP-1 Therapy
GLP-1 medications are superb at helping people eat less.
But science right now is very clear about this gap:
âś” We know how much people eat less
✔ We don’t yet know enough about the nutritional quality of what they eat
✔ And that “unknown” is critically important for sustained metabolic health and strength
In plain language:
Cutting calories alone isn’t the same thing as eating well.
Suppressing appetite won’t automatically provide the protein, nutrients or energy your body needs to preserve muscle, exercise effectively, stay mentally sharp, or maintain long-term metabolic health.
Why This Should Matter to Clinicians and Patients
This narrative review isn’t saying “don’t use GLP-1 drugs” — it’s saying:
👉 We must pair pharmacological appetite suppression with purposeful nutritional support
👉 We must prioritise whole foods, adequate protein and balanced macronutrients
👉 We must support patients with structured eating plans, not just reduced calories
That’s the missing piece if the goal isn’t merely temporary weight loss, but lasting metabolic health and strength.
Meet Malcolm Today!
Founder and General Manager of UltraLite Progam
Join UltraLite Today!
For 26 years, UltraLite’s healthy ketogenic program has changed lives. Join the success stories—or step up and help others succeed as an UltraLite practitioner.